Better living through microbes

被引：9

作者：

Baker, M

机构：

来源：

NATURE BIOTECHNOLOGY | 2005年 / 23卷 / 06期

关键词：

D O I：

10.1038/nbt0605-645

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

Genetically engineered bacteria made biotech drugs possible. Now, they are becoming drugs in their own right, Monya Baker reports.

引用

页码：645 / 647

页数：3

共 5 条

[1] Bacteriolytic therapy can generate a potent immune response against experimental tumors [J].

Agrawal, N ;

Bettegowda, C ;

Cheong, I ;

Geschwind, JF ;

Drake, CG ;

Hipkiss, EL ;

Tatsumi, M ;

Dang, LH ;

Diaz, LA ;

Pomper, M ;

Abusedera, M ;

Wahl, RL ;

Kinzler, KW ;

Zhou, SB ;

Huso, DL ;

Vogelstein, B .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (42) :15172-15177

[2] Listeria-based cancer vaccines that segregate immunogenicity from toxicity [J].

Brockstedt, DG ;

Giedlin, MA ;

Leong, ML ;

Bahjat, KS ;

Gao, Y ;

Luckett, W ;

Liu, WQ ;

Cook, DN ;

Portnoy, DA ;

Dubensky, TW .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (38) :13832-13837

[3] Pilot trial of genetically modified, attenuated Salmonella expressing the E-coli cytosine deaminase gene in refractory cancer patients [J].

Nemunaitis, J ;

Cunningham, C ;

Senzer, N ;

Kuhn, J ;

Cramm, J ;

Litz, C ;

Cavagnolo, R ;

Cahill, A ;

Clairmont, C ;

Sznol, M .

CANCER GENE THERAPY, 2003, 10 (10) :737-744

[4] Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10 [J].

Steidler, L ;

Neirynck, S ;

Huyghebaert, N ;

Snoeck, V ;

Vermeire, A ;

Goddeeris, B ;

Cox, E ;

Remon, JP ;

Remaut, E .

NATURE BIOTECHNOLOGY, 2003, 21 (07) :785-789

[5] Treatment of murine colitis by Lactococcus lactis secreting interleukin-10 [J].

Steidler, L ;

Hans, W ;

Schotte, L ;

Neirynck, S ;

Obermeier, F ;

Falk, W ;

Fiers, W ;

Remaut, E .

SCIENCE, 2000, 289 (5483) :1352-1355

← 1 →